NCT01544413

Brief Summary

Laparoscopic sentinel lymph node biopsy and stomach preserving surgery in ealry gastric cancer is less invasive method which can increase quality of life. Multicenter phase III trial is requred to validate this method. In this study all items which are necessary for laparoscopic sentinel lymph node biopsy are identified according to checklist and evaluated the performance completement.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
112

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Feb 2012

Typical duration for not_applicable

Geographic Reach
1 country

15 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2012

Completed
15 days until next milestone

First Submitted

Initial submission to the registry

February 16, 2012

Completed
18 days until next milestone

First Posted

Study publicly available on registry

March 5, 2012

Completed
2.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2014

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2014

Completed
Last Updated

December 16, 2014

Status Verified

December 1, 2014

Enrollment Period

2.6 years

First QC Date

February 16, 2012

Last Update Submit

December 14, 2014

Conditions

Keywords

laparoscopic sentinel lymph node biopsyquality control studyearly gastric cancer

Outcome Measures

Primary Outcomes (1)

  • Completement of performance of laparoscopic sentinel lymph node biopsy

    Investigators will make out a checklist after operation for evaluating the completement of performance of laparoscopic sentinel lymph node biopsy. The checklist will be made out within 24 hours.

    within 24 hours after operation

Secondary Outcomes (1)

  • Detection rate of laparoscopic sentinel lymph node, learning curve

    upto 2 years

Study Arms (1)

Laparoscopic sentinel lymph node biopsy

EXPERIMENTAL

This is a single armed study. After endoscopic marking using Tc99m HSA and indocyanine green fluid, Laparoscopic sentinel lymph node biopsy was performed and evalute at backtable.

Procedure: Laparoscopic sentinel lymph node biopsy

Interventions

During the operation, endoscopic marking was perfomed using Tc 99m HSA and indocyanine green around tumor. Then we identify the sentinel lymph node with laparoscopic probe. Laparoscopic sentinel lymph nodes were dissedted and evaluated them at the backtable in the operating room.

Also known as: Tc 99m HSA (Frosstimage), indocyanine green (IC-GREEN™ (Akorn)), laparoscopic probe (neoprobe® GDS gamma detection system)
Laparoscopic sentinel lymph node biopsy

Eligibility Criteria

Age20 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • gastric adenocarcinoma in preoperative endoscopic biopsy
  • clinical stage T1-2N0
  • long diameter of tumor \<4cm
  • distance between tumor and pylorus or cardia \>2cm
  • age: 20-80
  • ECOG: 1 or 0
  • patients will undergo laparoscopic gastrectomy

You may not qualify if:

  • definite criteria of endoscopic submucosal dissection (size\<2cm, differentiated type, no ulcer)
  • no indication for surgery for cardiovascular, pulmonary disease
  • pregancy
  • drug allergy or previous abdominal surgery, radiotherpy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (15)

Chonnam National University Hwasun Hospital

Hwasun, Chonnam, South Korea

Location

National Cancer Center, Korea

Goyang-si, Gyeonggi-do, 410-769, South Korea

Location

Ajou University School of Medicine

Suwon, Gyeonggi-do, South Korea

Location

Gyeongsang National University

Jinju, Gyeongsangnam-do, South Korea

Location

Korea University Guro Hospital

Seoul, Seoul, South Korea

Location

Yonsei Univeristy College of Medicine

Seoul, Seoul, South Korea

Location

Hallym University Sacred Heart Hospital

Anyang, South Korea

Location

Soonchunhyang University Bucheon Hospital

Bucheon-si, South Korea

Location

Dong-A University College of Medicine

Busan, South Korea

Location

Dongnam Institute of Radiological and Medical Science

Busan, South Korea

Location

Keimyung University School of Medicine

Daegu, South Korea

Location

Korea University College of Medicine

Seoul, South Korea

Location

Kyung Hee University Gangdong Hospital

Seoul, South Korea

Location

Seoul St. Mary's Hospital

Seoul, South Korea

Location

Yeouido St. Mary's Hospital

Seoul, South Korea

Location

MeSH Terms

Conditions

Stomach Neoplasms

Interventions

Indocyanine Green

Condition Hierarchy (Ancestors)

Gastrointestinal NeoplasmsDigestive System NeoplasmsNeoplasms by SiteNeoplasmsDigestive System DiseasesGastrointestinal DiseasesStomach Diseases

Intervention Hierarchy (Ancestors)

IndolesHeterocyclic Compounds, 2-RingHeterocyclic Compounds, Fused-RingHeterocyclic Compounds

Study Officials

  • Keun Won Ryu, Doctor

    National Cancer Center, Korea

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

February 16, 2012

First Posted

March 5, 2012

Study Start

February 1, 2012

Primary Completion

September 1, 2014

Study Completion

September 1, 2014

Last Updated

December 16, 2014

Record last verified: 2014-12

Locations